Umbilical-cord derived MSCs are currently being tested for numerous clinical applications due to their immunosuppressive and anti-inflammatory properties. In comparison to bone-marrow derived MSCs, these cells are more resilient, easier... The condition medium (CM) derived from these MSCs has also been implicated in therapeutic properties.
- Mechanism
- Curator reviewed
The factors contained in the CM are thought to hold differentiation and therapeutic function, additionally, they may also intensify the positive effects of cell-based therapies. Some of the growth factors and cytokines found include IL-6, VEGF, angiogenin, and IGF-1. Through these factors, the conditioned medium exerts numerous effects, including accelerated wound healing, anti-photo aging, and induced differentiation.
- Also known as
- Allogeneic Human Umbilical Derived Mesenchymal Stem Cells in Conditioned Media
- Code names
- Allogenic Human Umbilical Derived Mesenchymal Stem Cells in Conditioned Media
What you can answer from here — as of March 06, 2025
Which companies are running trials of Allogenic Human Umbilical Derived Mesenchymal Stem Cells in Conditioned Media, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account